This msg is sent on behalf of Prof. Eric Martz, University of Massachusetts, 
Amherst MA US

Coronavirus mutations reported within the past week by scientists in the UK 
have raised concern about an increased transmission rate of COVID-19. The 
report even temporarily closed the borders between the UK, France, and other EU 
countries, causing huge backups of trucking and supply concerns.

See the locations of the 4 most concerning mutations on a rotating 3D model of 
spike protein with interpretations of their likely consequences at this article 
posted December 22, 2020:

http://proteopedia.org/w/SARS-CoV-2_spike_protein_mutations

The article is written to be suitable for high-school students and higher. 
There are links to additional background material as well as references to 
reliable scientific publications and news sources.

The article offers a downloadable movie of the spike protein, slide 
presentation-ready, showing the conformational change when it is primed, with 
the locations of mutations indicated.

-Eric Martz

Professor Emeritus, Dept Microbiology (he/him/his)
University of Massachusetts, Amherst MA US
Martz.MolviZ.Org<http://Martz.MolviZ.Org> <http://martz.molviz.org/>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: 
<http://www.bioinformatics.org/pipermail/proteopedialist-for-users/attachments/20201223/bc8e1a52/attachment.html>
_______________________________________________
Proteopedialist-for-users mailing list
proteopedialist-for-us...@bioinformatics.org<mailto:proteopedialist-for-us...@bioinformatics.org>
http://www.bioinformatics.org/mm/listinfo/proteopedialist-for-users



########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to